 Connection
Alok Singh to Staphylococcus aureus
This is a "connection" page, showing publications Alok Singh has written about Staphylococcus aureus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.393 |
|
|
|
-
Kumar A, Boradia VM, Thakare R, Singh AK, Gani Z, Das S, Patidar A, Dasgupta A, Chopra S, Raje M, Raje CI. Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial. J Antimicrob Chemother. 2019 04 01; 74(4):912-920.
Score: 0.116
-
Pandey M, Singh AK, Thakare R, Talwar S, Karaulia P, Dasgupta A, Chopra S, Pandey AK. Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity. Sci Rep. 2017 09 14; 7(1):11521.
Score: 0.104
-
Thakare R, Singh AK, Das S, Vasudevan N, Jachak GR, Reddy DS, Dasgupta A, Chopra S. Repurposing Ivacaftor for treatment of Staphylococcus aureus infections. Int J Antimicrob Agents. 2017 Sep; 50(3):389-392.
Score: 0.103
-
Eakin AE, Green O, Hales N, Walkup GK, Bist S, Singh A, Mullen G, Bryant J, Embrey K, Gao N, Breeze A, Timms D, Andrews B, Uria-Nickelsen M, Demeritt J, Loch JT, Hull K, Blodgett A, Illingworth RN, Prince B, Boriack-Sjodin PA, Hauck S, MacPherson LJ, Ni H, Sherer B. Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agents. Antimicrob Agents Chemother. 2012 Mar; 56(3):1240-6.
Score: 0.070
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|